FDA reports second lowest count of veterinary company inspections in Delaware in 2025

Grace Graham, Deputy Commissioner for Policy, Legislation, and International Affairs of FDA
Grace Graham, Deputy Commissioner for Policy, Legislation, and International Affairs of FDA
0Comments

The FDA conducted three inspections across three veterinary companies in Delaware during 2025, according to the U.S. Food and Drug Administration (FDA).

This figure represented the second lowest number of inspections by company type conducted by the FDA in Delaware, accounting for 8.6% of all inspections that year.

Among Delaware’s veterinary companies, King Farm received the highest number of citations from the FDA in 2025.

The FDA routinely inspects facilities across the nation to determine if the workplace and their products are compliant with FDA-regulated laws and regulations implemented to improve overall public health. Inspection results are then disclosed publicly.

According to its website, the FDA is a government agency that is primarily responsible for monitoring the production and distribution of human and animal drugs, biological products, medical supplies and tobacco products for safety and quality.

FDA Inspections in Delaware During 2025
Project AreaNo Action IndicatedVoluntary Action IndicatedOfficial Action Indicated
Bioresearch Monitoring51—
Blood and Blood Products1——
Colors and Cosmetics Technology1——
Drug Quality Assurance—4—
Food Composition, Standards, Labeling and Econ1——
Foodborne Biological Hazards1421
Human Cellular, Tissue, and Gene Therapies2——
Monitoring of Marketed Animal Drugs, Feed, and Devices2—1
Information in this article was obtained from the U.S. Food and Drug Administration. The source data can be found here.



Related

Benjamin L. Wallace, U.S. Attorney for the District of Delaware

Former Delaware physician agrees to pay $180,000 in genetic testing fraud case

Dr. Shayasta S. Mufti has agreed to pay $180,000 after being accused of ordering unnecessary genetic tests for over 100 Medicare patients without proper examinations or consultations between April and November 2019 in Delaware. Authorities say such actions waste taxpayer money and threaten healthcare program integrity.

Martin A. Makary, M.D. Commissioner of Food and Drugs of FDA

FDA reports lowest Q1 inspection count for biologics companies in Delaware

During the first quarter of 2026, the U.S. Food and Drug Administration (FDA) carried out an inspection at a Biologics company in Delaware.

Mike Dunleavy, Governor of Alaska

Delaware sees 4.4% rise in individual income taxes collections in 2024

Out of the $6.5 billion in total tax revenue collected by Delaware in 2024, $2.5 billion came from individual income taxes, representing an increase from the previous year, when the total was $2.4 billion, according to the U.S. Census Bureau’s Annual Survey of State Government Tax Collections (STC).

Trending

The Weekly Newsletter

Sign-up for the Weekly Newsletter from First State Times.